GE HealthCare is trading at $80.05, up +4.54%, alongside a broad market rebound.

  • The S&P 500 is up 1.00%, the Nasdaq 1.23%, and the Dow 1.25%.
  • Recent Q3 results showed revenue growth of 7.2% and adjusted EPS growth of 25.1%; management also raised 2026 guidance. These developments are supportive but not confirmed as today’s direct catalyst.
  • GE HealthCare announced its Allia Celeo system on November 1; no explicit link to the share move was reported.